| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c0301c92b08ff9f99883b2bc37acb75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5f51ccf671df628af90d2747357c19b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb3ec191e9624bd1c4e1e89afcfc54b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3c02833bd037dc982a7e8590198621c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee442d0fdb984e8567debf884bdb2441 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51eea803f20dc5ed1e253a344d31d1ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc1fcc4f8b0456bf3e74131027104dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b527043b732c6c3f583dd25aa05916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b72e15794cee8554f921bb09bc2a7bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc57eddbda485787d57c284a4e4fe1bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38dbccb7ef813a26045fe97779de3944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e1e3b9c47030884682a6c289015822c |
| publicationDate |
2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2963124-A1 |
| titleOfInvention |
Biomarker combinations for use in pancreatic cancer screening |
| abstract |
The present invention describes a biomarker-based method to aid in the early diagnosis of pancreatic cancer. Specifically the measurement of relative levels or concentrations of biomarkers in vitro from a sample taken from a patient are measured. Combinations of biomarkers provided may be useful in the diagnosis of pancreatic cancer but also for monitoring the progression or recurrence of pancreatic cancer and also the effectiveness of any treatment strategy which has been implemented. The current invention can also be used to determine persons at risk of developing pancreatic cancer, for example by aiding in the diagnosis of pancreatic adenoma, a pre-malignant condition that may develop into pancreatic cancer. |
| priorityDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |